Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2009 2
2011 1
2014 1
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Safety of mTOR inhibitors in adult solid organ transplantation.
Ventura-Aguiar P, Campistol JM, Diekmann F. Ventura-Aguiar P, et al. Expert Opin Drug Saf. 2016;15(3):303-19. doi: 10.1517/14740338.2016.1132698. Epub 2016 Jan 28. Expert Opin Drug Saf. 2016. PMID: 26667069 Review.
In the liver, conversion 4 weeks post-transplantation may reduce long-term chronic kidney disease secondary to calcineurin nephrotoxicity, without increasing hepatic artery/portal vein thrombosis....
In the liver, conversion 4 weeks post-transplantation may reduce long-term chronic kidney disease secondary to calcineurin nephrot
Chronic Allograft Injury: An Overview of Pathogenesis and Treatment Strategies.
Madariaga HM, Riella LV. Madariaga HM, et al. Contrib Nephrol. 2017;190:168-180. doi: 10.1159/000468963. Epub 2017 May 23. Contrib Nephrol. 2017. PMID: 28535528 Review.
In this review, we will address the latest evidence on CAI, potential etiologies and risk factors including non-adherence, antibody-mediated rejection, recurrence of glomerular disease, BK nephropathy, and calcineurin nephrotoxicity....
In this review, we will address the latest evidence on CAI, potential etiologies and risk factors including non-adherence, antibody-mediated …
The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging.
Joosten SA, van Kooten C, Sijpkens YW, de Fijter JW, Paul LC. Joosten SA, et al. Kidney Int. 2004 May;65(5):1556-9. doi: 10.1111/j.1523-1755.2004.05410.x. Kidney Int. 2004. PMID: 15086891 Free article. Review.
Chronic allograft nephropathy includes chronic calcineurin nephrotoxicity, recurrent and de novo glomerulonephritis and a group of disorders with graft dysfunction of unknown etiology designated chronic rejection. ...
Chronic allograft nephropathy includes chronic calcineurin nephrotoxicity, recurrent and de novo glomerulonephritis and a grou …
Evolution and pathophysiology of renal-transplant glomerulosclerosis.
Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. Nankivell BJ, et al. Transplantation. 2004 Aug 15;78(3):461-8. doi: 10.1097/01.tp.0000128612.75163.26. Transplantation. 2004. PMID: 15316377
An intense but limited peak of damage in the first month was associated with cold ischemia (P<0.05) and calcineurin nephrotoxicity (P<0.001). GS then occurred as a late consequence of earlier immune-mediated tubular damage (9.3+/-6.6%, P<0.01 vs. no damage) …
An intense but limited peak of damage in the first month was associated with cold ischemia (P<0.05) and calcineurin nephrotoxic
Combined heart and liver transplantation: a single-center experience.
Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Raichlin E, et al. Transplantation. 2009 Jul 27;88(2):219-25. doi: 10.1097/TP.0b013e3181ac60db. Transplantation. 2009. PMID: 19623017
Three patients developed end-stage renal failure secondary to calcineurin nephrotoxicity. CONCLUSION: Simultaneous heart and liver transplantation is feasible and achieved excellent results for selected patients....
Three patients developed end-stage renal failure secondary to calcineurin nephrotoxicity. CONCLUSION: Simultaneous heart and l …
Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study.
Sutherland AI, Akhtar MZ, Zilvetti M, Brockmann J, Ruse S, Fuggle SV, Sinha S, Harden P, Friend PJ. Sutherland AI, et al. Am J Transplant. 2014 Mar;14(3):677-84. doi: 10.1111/ajt.12572. Am J Transplant. 2014. PMID: 24612687 Free article.
mTOR inhibitors avoid calcineurin nephrotoxicity, but sirolimus de novo is associated with unacceptable side effects and higher rejection rates. ...
mTOR inhibitors avoid calcineurin nephrotoxicity, but sirolimus de novo is associated with unacceptable side effects and highe …
Renal histopathological lesions after orthotopic liver transplantation (OLT).
Pillebout E, Nochy D, Hill G, Conti F, Antoine C, Calmus Y, Glotz D. Pillebout E, et al. Am J Transplant. 2005 May;5(5):1120-9. doi: 10.1111/j.1600-6143.2005.00852.x. Am J Transplant. 2005. PMID: 15816895 Free article.
Thus, CRF in OLT recipients is more complex than originally thought and should not be classified as anti-calcineurin nephrotoxicity without further investigations, including renal histology. ...
Thus, CRF in OLT recipients is more complex than originally thought and should not be classified as anti-calcineurin nephrotoxicit
Histological findings of early graft biopsies in old donor renal transplant patients receiving induction therapy.
Gavela E, Pallardó LM, Sancho A, Avilla A, Beltrán S, Roselló E, Pérez ML, García F. Gavela E, et al. Transplant Proc. 2009 Jul-Aug;41(6):2099-101. doi: 10.1016/j.transproceed.2009.06.058. Transplant Proc. 2009. PMID: 19715842
Histological evaluation showed: acute tabular necrosis in 7 (78%) Thymoglobulin patients versus 14 (45%) basiliximab patients, with calcineurin nephrotoxicity in 2 (22%) and 1 (3.2%), respectively. An acute rejection episode was not diagnosed in the Thymoglobulin gr …
Histological evaluation showed: acute tabular necrosis in 7 (78%) Thymoglobulin patients versus 14 (45%) basiliximab patients, with calci